| Application number | Title of the application | Filing Date | Status |
|---|
| 09/914815 | Leukocyte-and blood-associated proteins | Mar 28, 2002 | Abandoned |
Array
(
[id] => 5788283
[patent_doc_number] => 20020160934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'Nucleic acid sequences from Drosophila melanogaster that encode proteins essential for larval viability and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/108605
[patent_app_country] => US
[patent_app_date] => 2002-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13175
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20020160934.pdf
[firstpage_image] =>[orig_patent_app_number] => 10108605
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/108605 | Nucleic acid sequences from Drosophila melanogaster that encode proteins essential for larval viability and uses thereof | Mar 26, 2002 | Abandoned |
| 10/107545 | Modified aequorin with enhanced glowing kinetics and methods of use | Mar 24, 2002 | Abandoned |
Array
(
[id] => 7471408
[patent_doc_number] => 20040096953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-20
[patent_title] => 'Thrombin derivatives and process for producing the same, anhydrothrombin derivatives and process for producing the same, platelet agglutination-inducing composition, method of inducing platelet agglutination, clinical test reagents, clinical test method, thrombosis inhibitors, adsorbent and process for producing the same,'
[patent_app_type] => new
[patent_app_number] => 10/472237
[patent_app_country] => US
[patent_app_date] => 2003-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7488
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20040096953.pdf
[firstpage_image] =>[orig_patent_app_number] => 10472237
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/472237 | THROMBIN DERIVATIVES AND PROCESS FOR PRODUCING THE SAME, ANHYDROTHROMBIN DERIVATIVES AND PROCESS FOR PRODUCING THE SAME, PLATELET AGGLUTINATION-INDUCING COMPOSITIONS, METHOD OF INDUCING PLATELET AGGLUTINATION, CLINICAL TEST REAGENTS, CLINICAL TEST METHOD, THROMBOSIS INHIBITORS, ADSORBENT AND PROCESS FOR PRODUCING THE SAME | Mar 18, 2002 | Issued |
| 10/069982 | Formulations for parenteral use of estramustine phosphate and amino acids | Mar 13, 2002 | Abandoned |
Array
(
[id] => 798002
[patent_doc_number] => 07427589
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-23
[patent_title] => 'Use of cytokine inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/092919
[patent_app_country] => US
[patent_app_date] => 2002-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5182
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/427/07427589.pdf
[firstpage_image] =>[orig_patent_app_number] => 10092919
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/092919 | Use of cytokine inhibitors | Mar 7, 2002 | Issued |
| 10/018251 | Substance binding to the substrate of activated blood coagulation factor in competition with this factorto thereby regulate the reaction between the activated blood coagulation factor and the substrate, a process for producing the substance and blood coagulation factor-adsorbent with the use of the substance | Mar 3, 2002 | Abandoned |
| 09/913229 | Process for the preparation of cyclic tetrapeptide derivatives | Feb 26, 2002 | Abandoned |
Array
(
[id] => 972052
[patent_doc_number] => 06936437
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-08-30
[patent_title] => 'Methods and compositions for production of recombinant peptides'
[patent_app_type] => utility
[patent_app_number] => 10/080919
[patent_app_country] => US
[patent_app_date] => 2002-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 17531
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/936/06936437.pdf
[firstpage_image] =>[orig_patent_app_number] => 10080919
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/080919 | Methods and compositions for production of recombinant peptides | Feb 21, 2002 | Issued |
Array
(
[id] => 6176535
[patent_doc_number] => 20020155614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-24
[patent_title] => 'Peptide esterification'
[patent_app_type] => new
[patent_app_number] => 10/081379
[patent_app_country] => US
[patent_app_date] => 2002-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10306
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20020155614.pdf
[firstpage_image] =>[orig_patent_app_number] => 10081379
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/081379 | Peptide esterification | Feb 20, 2002 | Abandoned |
Array
(
[id] => 456662
[patent_doc_number] => 07244721
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-17
[patent_title] => 'Peptides as NS3-serine protease inhibitors of hepatitis C virus'
[patent_app_type] => utility
[patent_app_number] => 10/052386
[patent_app_country] => US
[patent_app_date] => 2002-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50340
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/244/07244721.pdf
[firstpage_image] =>[orig_patent_app_number] => 10052386
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/052386 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | Jan 17, 2002 | Issued |
Array
(
[id] => 6711112
[patent_doc_number] => 20030170861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Cellobiohydrolase I gene and improved variants'
[patent_app_type] => new
[patent_app_number] => 10/031496
[patent_app_country] => US
[patent_app_date] => 2002-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7934
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 1
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170861.pdf
[firstpage_image] =>[orig_patent_app_number] => 10031496
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/031496 | Cellobiohydrolase I gene and improved variants | Jan 13, 2002 | Issued |
Array
(
[id] => 968423
[patent_doc_number] => 06939697
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-09-06
[patent_title] => 'Process to concentrate insoluble proteins by vibrating membrane filtration'
[patent_app_type] => utility
[patent_app_number] => 10/250818
[patent_app_country] => US
[patent_app_date] => 2002-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10317
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/939/06939697.pdf
[firstpage_image] =>[orig_patent_app_number] => 10250818
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/250818 | Process to concentrate insoluble proteins by vibrating membrane filtration | Jan 6, 2002 | Issued |
Array
(
[id] => 1030962
[patent_doc_number] => 06878513
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-04-12
[patent_title] => 'Modified gelatin, and silver halide photographic emulsion and photographic light-sensitive material using the same'
[patent_app_type] => utility
[patent_app_number] => 10/026843
[patent_app_country] => US
[patent_app_date] => 2001-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50788
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/878/06878513.pdf
[firstpage_image] =>[orig_patent_app_number] => 10026843
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/026843 | Modified gelatin, and silver halide photographic emulsion and photographic light-sensitive material using the same | Dec 26, 2001 | Issued |
Array
(
[id] => 999577
[patent_doc_number] => 06911428
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-06-28
[patent_title] => 'Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virus'
[patent_app_type] => utility
[patent_app_number] => 10/013071
[patent_app_country] => US
[patent_app_date] => 2001-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16033
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/911/06911428.pdf
[firstpage_image] =>[orig_patent_app_number] => 10013071
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/013071 | Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virus | Dec 9, 2001 | Issued |
Array
(
[id] => 642196
[patent_doc_number] => 07122629
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-17
[patent_title] => 'Human cDNAs and proteins and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/001142
[patent_app_country] => US
[patent_app_date] => 2001-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 190635
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/122/07122629.pdf
[firstpage_image] =>[orig_patent_app_number] => 10001142
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/001142 | Human cDNAs and proteins and uses thereof | Nov 13, 2001 | Issued |
Array
(
[id] => 6710879
[patent_doc_number] => 20030170628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Human cDNAs and proteins and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/999570
[patent_app_country] => US
[patent_app_date] => 2001-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 191874
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170628.pdf
[firstpage_image] =>[orig_patent_app_number] => 09999570
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/999570 | Human cDNAs and proteins and uses thereof | Nov 13, 2001 | Issued |
Array
(
[id] => 6847344
[patent_doc_number] => 20030166511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Cardioprotective composition comprising ceruloplasmin and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/021691
[patent_app_country] => US
[patent_app_date] => 2001-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9255
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166511.pdf
[firstpage_image] =>[orig_patent_app_number] => 10021691
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/021691 | Cardioprotective composition comprising ceruloplasmin and uses thereof | Nov 4, 2001 | Abandoned |
Array
(
[id] => 707379
[patent_doc_number] => 07060462
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-13
[patent_title] => 'AopB gene, protein,homologs, fragments and variants thereof, and their use for cell surface display'
[patent_app_type] => utility
[patent_app_number] => 10/415554
[patent_app_country] => US
[patent_app_date] => 2001-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 28313
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/060/07060462.pdf
[firstpage_image] =>[orig_patent_app_number] => 10415554
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/415554 | AopB gene, protein,homologs, fragments and variants thereof, and their use for cell surface display | Oct 31, 2001 | Issued |
Array
(
[id] => 7399482
[patent_doc_number] => 20040039177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Stimulus responsive affinity chromatographic material and separation/purification method'
[patent_app_type] => new
[patent_app_number] => 10/381120
[patent_app_country] => US
[patent_app_date] => 2003-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7357
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20040039177.pdf
[firstpage_image] =>[orig_patent_app_number] => 10381120
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/381120 | Stimulus responsive affinity chromatographic material and separation/purification method | Oct 14, 2001 | Issued |